Advisory Services Network, LLC Intellia Therapeutics, Inc. Transaction History

Advisory Services Network, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$23.16 - $32.34 $36,523 - $51,000	1,577 New	1,577 $48,000
Q1 2023 May 17, 2023	SELL	$33.3 - $44.82 $6,493 - $8,739	-195 Reduced 13.39%	1,261 $46,000
Q4 2022 Feb 13, 2023	BUY	$33.21 - $62.69 $48,353 - $91,276	1,456 New	1,456 $50,000
Q3 2021 Nov 05, 2021	SELL	$132.37 - $176.78 $26,474 - $35,356	-200 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$60.88 - $161.91 $12,176 - $32,382	200 New	200 $32,000
Q1 2021 May 24, 2021	SELL	$46.59 - $83.68 $13,977 - $25,104	-300 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$18.83 - $63.53 $5,498 - $18,550	292 Added 3650.0%	300 $16,000
Q3 2020 Nov 16, 2020	BUY	$17.47 - $24.93 $139 - $199	8 New	8 $0

316

91.7M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $722M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.